title: Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.
abstract: Clostridium difficile is the most common cause of antibacterial-associated diarrhea. Clear clinical presentation and rapid diagnostics enable targeted therapy for C. difficile infection (CDI) to start quickly. CDI treatment includes metronidazole and vancomycin (VAN). Despite decades of use for CDI, no clinically meaningful resistance to either agent has emerged. Fidaxomicin (FDX), an RNA polymerase inhibitor, is also approved to treat CDI. Mutants with reduced susceptibility to FDX have been selected in vitro by single and multistep methods. Strains with elevated FDX minimum inhibitory concentrations (MICs) were also identified from FDX-treated patients in clinical trials. LFF571 is an exploratory agent that inhibits EF-Tu. In a proof-of-concept study, LFF571 was safe and effective for treating CDI. Spontaneous mutants with reduced susceptibility to LFF571 were selected in vitro in a single step, but not via serial passage. Although there are several agents in development for treatment of CDI, this review summarizes the frequencies and mechanisms of C. difficile mutants displaying reduced susceptibility to FDX or LFF71.
authors.affiliation: Infectious Disease Area, Novartis Institutes for BioMedical Research, Emeryville, California 94608.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Leeds
mesh_terms: D000617:Aminoglycosides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016360:Clostridioides difficile / Q000187:drug effects / Q000235:genetics; D003015:Clostridium Infections / Q000188:drug therapy*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D000077732:Fidaxomicin; D005838:Genotype; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D013844:Thiazoles / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D010456:Peptides, Cyclic
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000077732:Fidaxomicin; D013844:Thiazoles; C573298:LFF571; D010456:Peptides, Cyclic
references.citation: J Infect Dis. 2014 May 1;209(9):1446-51
references.pmid: 24218500
references.citation: J Med Chem. 2015 Jun 25;58(12):5137-42
references.pmid: 25993059
references.citation: BMC Genomics. 2008 Feb 27;9:102
references.pmid: 18304323
references.citation: J Antibiot (Tokyo). 1975 Apr;28(4):253-9
references.pmid: 807545
references.citation: Antimicrob Agents Chemother. 2012 Aug;56(8):4463-5
references.pmid: 22644023
references.citation: Antimicrob Agents Chemother. 2006 Jan;50(1):401-2
references.pmid: 16377724
references.citation: Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499
references.pmid: 23439232
references.citation: Aliment Pharmacol Ther. 2013 Jan;37(1):122-8
references.pmid: 23095030
references.citation: J Antibiot (Tokyo). 1994 Dec;47(12):1564-7
references.pmid: 7844053
references.citation: Antimicrob Agents Chemother. 2012 May;56(5):2493-503
references.pmid: 22290948
references.citation: N Engl J Med. 2014 Mar 27;370(13):1198-208
references.pmid: 24670166
references.citation: J Bacteriol. 2000 Dec;182(24):6913-20
references.pmid: 11092850
references.citation: Antimicrob Agents Chemother. 1991 Jun;35(6):1108-11
references.pmid: 1929250
references.citation: J Antibiot (Tokyo). 1997 Jan;50(1):22-6
references.pmid: 9066762
references.citation: Chem Biol. 2000 May;7(5):R109-19
references.pmid: 10801476
references.citation: Proc Natl Acad Sci U S A. 1975 Dec;72(12):4780-4
references.pmid: 1108000
references.citation: J Am Chem Soc. 2009 Apr 29;131(16):5946-55
references.pmid: 19338336
references.citation: Curr Opin Microbiol. 2011 Oct;14(5):532-43
references.pmid: 21862392
references.citation: Nat Prod Rep. 2005 Apr;22(2):162-95
references.pmid: 15806196
references.citation: Clin Microbiol Infect. 2009 Dec;15(12):1067-79
references.pmid: 19929973
references.citation: Curr Top Med Chem. 2014;14(1):152-75
references.pmid: 24236721
references.citation: J Med Microbiol. 2011 Aug;60(Pt 8):1213-7
references.pmid: 21349983
references.citation: Antimicrob Agents Chemother. 2015 Mar;59(3):1435-40
references.pmid: 25534727
references.citation: Antimicrob Agents Chemother. 2007 May;51(5):1840-3
references.pmid: 17307985
references.citation: Antimicrob Agents Chemother. 2006 Sep;50(9):3028-32
references.pmid: 16940098
references.citation: Clin Infect Dis. 2012 Aug;55 Suppl 2:S116-20
references.pmid: 22752859
references.citation: Antimicrob Agents Chemother. 2015 Feb;59(2):1252-7
references.pmid: 25512411
references.citation: Antimicrob Agents Chemother. 2012 Nov;56(11):5946-51
references.pmid: 22964250
references.citation: J Bacteriol. 1989 Jan;171(1):581-4
references.pmid: 2492503
references.citation: Int J Antimicrob Agents. 2009 Dec;34(6):605-6
references.pmid: 19683897
references.citation: Antimicrob Agents Chemother. 2014;58(2):892-900
references.pmid: 24277020
references.citation: Clin Infect Dis. 2012 Aug;55 Suppl 2:S127-31
references.pmid: 22752861
references.citation: Clin Infect Dis. 2012 Aug;55 Suppl 2:S143-8
references.pmid: 22752863
references.citation: Clin Microbiol Infect. 2015 Mar;21(3):248.e9-248.e16
references.pmid: 25701178
references.citation: Nat Prod Commun. 2014 Feb;9(2):237-40
references.pmid: 24689300
references.citation: Antimicrob Agents Chemother. 2013 Jan;57(1):664-7
references.pmid: 23147724
references.citation: JAMA. 2015 Jan 27;313(4):398-408
references.pmid: 25626036
references.citation: Antimicrob Agents Chemother. 2015 Mar;59(3):1441-5
references.pmid: 25534724
references.citation: N Engl J Med. 2005 Dec 8;353(23):2433-41
references.pmid: 16322603
references.citation: Nature. 1975 Oct 9;257(5526):458-62
references.pmid: 1101072
references.citation: Clin Microbiol Infect. 2014 Mar;20 Suppl 2:1-26
references.pmid: 24118601
references.citation: J Antimicrob Chemother. 1987 Oct;20(4):467-76
references.pmid: 3316149
references.citation: J Bacteriol. 1977 Oct;132(1):73-9
references.pmid: 410787
references.citation: J Med Chem. 2012 Mar 8;55(5):2376-87
references.pmid: 22315981
references.citation: Drug Discov Today. 2015 May;20(5):602-8
references.pmid: 25499664
references.citation: J Antibiot (Tokyo). 1991 Jul;44(7):693-701
references.pmid: 1908853
references.citation: J Antimicrob Chemother. 2014 Jan;69(1):41-4
references.pmid: 23887866
references.citation: FEBS Lett. 2006 Aug 21;580(19):4576-81
references.pmid: 16876786
references.citation: Antimicrob Agents Chemother. 2005 Jan;49(1):131-6
references.pmid: 15616286
references.citation: J Antimicrob Chemother. 2008 Oct;62(4):713-9
references.pmid: 18587134
references.citation: J Antibiot (Tokyo). 1975 Jul;28(7):543-9
references.pmid: 807550
references.citation: Clin Microbiol Infect. 2014 Dec;20(12):O1067-74
references.pmid: 25040463
references.citation: Annu Rev Biochem. 2013;82:203-36
references.pmid: 23746255
references.citation: Biochim Biophys Acta. 1972 Apr 26;269(1):62-6
references.pmid: 4554651
references.citation: J Antibiot (Tokyo). 1986 Oct;39(10):1407-12
references.pmid: 3781911
references.citation: Bioconjug Chem. 2004 Mar-Apr;15(2):333-43
references.pmid: 15025529
references.citation: Lancet Infect Dis. 2012 Apr;12(4):281-9
references.pmid: 22321770
references.citation: Biochemistry. 2000 Jan 11;39(1):37-45
references.pmid: 10625477
references.citation: Biochemistry. 1996 Dec 3;35(48):15288-94
references.pmid: 8952479
references.citation: Antimicrob Agents Chemother. 2015 Jul;59(7):4139-47
references.pmid: 25941217
references.citation: J Mol Biol. 2000 Dec 15;304(5):995-1005
references.pmid: 11124042
references.citation: Antimicrob Agents Chemother. 2014;58(2):901-8
references.pmid: 24277035
references.citation: Clin Infect Dis. 2015 May 15;60 Suppl 2:S66-71
references.pmid: 25922403
references.citation: J Antibiot (Tokyo). 1987 May;40(5):567-74
references.pmid: 3610815
references.citation: Antimicrob Agents Chemother. 2014 Jul;58(7):3976-82
references.pmid: 24798273
references.citation: Biochem Biophys Res Commun. 1997 Jan 13;230(2):320-6
references.pmid: 9016775
references.citation: Biochem Biophys Res Commun. 1970 Mar 27;38(6):1016-22
references.pmid: 5432207
references.citation: N Engl J Med. 2011 Feb 3;364(5):422-31
references.pmid: 21288078
references.citation: Nature. 1997 Sep 25;389(6649):403-6
references.pmid: 9311785
references.citation: Antimicrob Agents Chemother. 2014 May;58(5):2934-7
references.pmid: 24550338
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):5194-9
references.pmid: 21844318
references.citation: Infect Control Hosp Epidemiol. 2010 May;31(5):431-55
references.pmid: 20307191
references.citation: N Engl J Med. 2015 Feb 26;372(9):825-34
references.pmid: 25714160
references.citation: J Antimicrob Chemother. 2013 Jun;68(6):1305-11
references.pmid: 23420839